Page last updated: 2024-08-26

arsenic and Antibody Deficiency Syndrome

arsenic has been researched along with Antibody Deficiency Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen, FJ; Gui, D; Ikezoe, T; Koeffler, HP; Kumagai, T; O'Kelly, J; Said, JW; Tong, XJ	1
Baranda, L; de la Fuente, H; Díaz-Barriga, F; González-Amaro, R; Layseca, E; Portales-Pérez, D; Saavedra-Alanís, V	1

Other Studies

2 other study(ies) available for arsenic and Antibody Deficiency Syndrome

Article	Year
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-15, Volume: 10, Issue:4 Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; CD36 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Survival; Genetic Linkage; Humans; Immunologic Deficiency Syndromes; Ligands; Luciferases; Male; Mice; Multiple Myeloma; Oxides; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection; U937 Cells; X Chromosome	2004
Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells. Clinical and experimental immunology, 2002, Volume: 129, Issue:1 Topics: Adult; Apoptosis; Arsenic; Arsenites; Cadmium; Cadmium Chloride; Cells, Cultured; Child; Creatinine; Dose-Response Relationship, Drug; Environmental Exposure; Environmental Pollutants; Humans; Immunologic Deficiency Syndromes; Lead; Leukocytes, Mononuclear; Mexico; Mining; Organometallic Compounds; Rosette Formation; Sodium Compounds; T-Lymphocytes	2002

Article

Year

RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-15, Volume: 10, Issue:4

Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; CD36 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Survival; Genetic Linkage; Humans; Immunologic Deficiency Syndromes; Ligands; Luciferases; Male; Mice; Multiple Myeloma; Oxides; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection; U937 Cells; X Chromosome

2004

Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells.

Clinical and experimental immunology, 2002, Volume: 129, Issue:1

Topics: Adult; Apoptosis; Arsenic; Arsenites; Cadmium; Cadmium Chloride; Cells, Cultured; Child; Creatinine; Dose-Response Relationship, Drug; Environmental Exposure; Environmental Pollutants; Humans; Immunologic Deficiency Syndromes; Lead; Leukocytes, Mononuclear; Mexico; Mining; Organometallic Compounds; Rosette Formation; Sodium Compounds; T-Lymphocytes

2002